60 Degrees Pharma gets safety board clearance for babesiosis trial
Tweet Send to a Friend
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) announced that an independent Data Safety Monitoring Board has recommended continuation of its B-Free ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


